2,497 results
·
34ms
·
Sources: EU EUDAMED, US FDA
Filters
Classification: FDA Class 2
×
Lipoprotein, Low-Density, Antigen, Antiserum, Control
FDA classification
FDA Class 2
·Lipoprotein, Low-Density, Antigen, Antiserum, Control
Generator, Low Voltage, Therapeutic X-Ray
FDA classification
FDA Class 2
·Generator, Low Voltage, Therapeutic X-Ray
Collimator, Low Voltage, Therapeutic X-Ray
FDA classification
FDA Class 2
·Collimator, Low Voltage, Therapeutic X-Ray
Low Dead Space Needle, Single Lumen, Hypodermic
FDA classification
FDA Class 2
·Low Dead Space Needle, Single Lumen, Hypodermic
Low Energy Direct Current Thermal Ablation System
FDA classification
FDA Class 2
·Low Energy Direct Current Thermal Ablation System
Assay, Hybridization And/Or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,Hepatitis C Virus
FDA Pre-Market Approval
FDA Class 2
·COBAS HCV TEST
Assay, Hybridization And/Or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,Hepatitis C Virus
FDA Pre-Market Approval
FDA Class 2
·AMPLICOR HEPATITIS C VIRUS (HCV) TEST
Assay, Hybridization And/Or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,Hepatitis C Virus
FDA Pre-Market Approval
FDA Class 2
·cobas HCV
Assay, Hybridization And/Or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,Hepatitis C Virus
FDA Pre-Market Approval
FDA Class 2
·cobas HCV Test
Assay, Hybridization And/Or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,Hepatitis C Virus
FDA Pre-Market Approval
FDA Class 2
·Cobas HCV Test
Assay, Hybridization And/Or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,Hepatitis C Virus
FDA Pre-Market Approval
FDA Class 2
·COBAS AMPLIPREP/COBAS TAQMAN HCV TEST VERSION 2.0, COBAS TAQMAN HCV TEST VERSION 2.0 FOR USE WITH THE HIGH PURE SYSTEM
Assay, Hybridization And/Or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,Hepatitis C Virus
FDA Pre-Market Approval
FDA Class 2
·BAYER VERSANT HCV RNA 3.0 ASSAY (BDNA)
Assay, Hybridization And/Or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,Hepatitis C Virus
FDA Pre-Market Approval
FDA Class 2
·VERSANT HCV RNA 3.0 ASSAY (BDNA)
Assay, Hybridization And/Or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,Hepatitis C Virus
FDA Pre-Market Approval
FDA Class 2
·COBAS AMPLICOR (TM) HEPATITIS C VIRUS (HCV) TEST, V2.0
Assay, Hybridization And/Or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,Hepatitis C Virus
FDA Pre-Market Approval
FDA Class 2
·COBAS TaqMan HCV Test, v2.0 for use on the High Pure System
Assay, Hybridization And/Or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,Hepatitis C Virus
FDA Pre-Market Approval
FDA Class 2
·AMPLICOR HEPATITIS C VIRUS (HCV) TEST VERSION 2.0
Assay, Hybridization And/Or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,Hepatitis C Virus
FDA Pre-Market Approval
FDA Class 2
·Aptima HCV Quant Dx Assay
Assay, Hybridization And/Or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,Hepatitis C Virus
FDA Pre-Market Approval
FDA Class 2
·AMPLICOR HCV TEST, VERSION 2.0
Assay, Hybridization And/Or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,Hepatitis C Virus
FDA Pre-Market Approval
FDA Class 2
·Cobas AmpliPrep/Cobas TaqMan HCV Test, v2.0
Assay, Hybridization And/Or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,Hepatitis C Virus
FDA Pre-Market Approval
FDA Class 2
·APTIMA HCV RNA QUALITATIVE ASSAY